Good reasons to get out: LYMPRO validation by I
Post# of 30028
Posted On: 12/26/2014 3:08:01 PM
Good reasons to get out:
LYMPRO validation by ICON
LYMPRO approval for RUO this quarter
LP--002 revised study to be released in 3 days
MANF RP approved for FDA Orphan,
Plus a 2nd Orphan indication application submitted,
Plus Eltoprazine phase IIb trial set to begin early 2015,
Plus ESS acquisition to close 4th quarter 2014, plus LP-002 number to be released 4th quarter 2014
Yup, lots of reasons to be selling here if you're off your meds...and out of your mind. The only selling going on here I believe are manipulators, trying to shake people out. Time is running out, and they know it. "Hold,Hold, Hold,"..............
LYMPRO validation by ICON
LYMPRO approval for RUO this quarter
LP--002 revised study to be released in 3 days
MANF RP approved for FDA Orphan,
Plus a 2nd Orphan indication application submitted,
Plus Eltoprazine phase IIb trial set to begin early 2015,
Plus ESS acquisition to close 4th quarter 2014, plus LP-002 number to be released 4th quarter 2014
Yup, lots of reasons to be selling here if you're off your meds...and out of your mind. The only selling going on here I believe are manipulators, trying to shake people out. Time is running out, and they know it. "Hold,Hold, Hold,"..............
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼